Advertisement
IMCC vs TXMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCC is a Hold and TXMD is a Hold.
IMCC in -4.08% downward trend, sliding for three consecutive days on November 10, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IMCC declined for three days, in 376 of 401 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Aroon Indicator for IMCC entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IMCC's RSI Oscillator exited the oversold zone, 40 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
Following a +6.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMCC advanced for three days, in 162 of 192 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
IMCC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.070) is normal, around the industry mean (6.379). P/E Ratio (-0.006) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.011) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. IMCC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMCC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
TXMD in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 05, 2026
TXMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 42 cases where TXMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TXMD's RSI Indicator exited the oversold zone, 28 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 76 cases where TXMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
Following a +2.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where TXMD advanced for three days, in 145 of 206 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TXMD as a result. In 92 of 110 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for TXMD turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 44 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TXMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for TXMD entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.742) is normal, around the industry mean (6.379). P/E Ratio (-87.000) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (7.740) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. TXMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TXMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
IMCC | TXMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 53 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 26 Undervalued | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 91 | |
PRICE GROWTH RATING 1..100 | 97 | 63 | |
P/E GROWTH RATING 1..100 | 100 | 98 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TXMD's Valuation (5) in the Pharmaceuticals Generic industry is in the same range as IMCC (26) in the null industry. This means that TXMD’s stock grew similarly to IMCC’s over the last 12 months.
TXMD's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as IMCC (100) in the null industry. This means that TXMD’s stock grew similarly to IMCC’s over the last 12 months.
TXMD's SMR Rating (91) in the Pharmaceuticals Generic industry is in the same range as IMCC (100) in the null industry. This means that TXMD’s stock grew similarly to IMCC’s over the last 12 months.
TXMD's Price Growth Rating (63) in the Pharmaceuticals Generic industry is somewhat better than the same rating for IMCC (97) in the null industry. This means that TXMD’s stock grew somewhat faster than IMCC’s over the last 12 months.
TXMD's P/E Growth Rating (98) in the Pharmaceuticals Generic industry is in the same range as IMCC (100) in the null industry. This means that TXMD’s stock grew similarly to IMCC’s over the last 12 months.
| IMCC | TXMD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 74% |
| Stochastic ODDS (%) | N/A | 2 days ago 72% |
| Momentum ODDS (%) | N/A | 2 days ago 84% |
| MACD ODDS (%) | N/A | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 86% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 84% |
| Advances ODDS (%) | 14 days ago 84% | 14 days ago 70% |
| Declines ODDS (%) | 2 days ago 90% | 20 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 83% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IMCC’s FA Score shows that 1 FA rating(s) are green while TXMD’s FA Score has 1 green FA rating(s).
- IMCC’s FA Score: 1 green, 4 red.
- TXMD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IMCC’s TA Score shows that 3 TA indicator(s) are bullish while TXMD’s TA Score has 4 bullish TA indicator(s).
- IMCC’s TA Score: 3 bullish, 2 bearish.
- TXMD’s TA Score: 4 bullish, 4 bearish.
Price Growth
IMCC (@Pharmaceuticals: Generic) experienced а -15.50% price change this week, while TXMD (@Pharmaceuticals: Generic) price change was -2.25% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.
Reported Earning Dates
IMCC is expected to report earnings on Nov 12, 2026.
TXMD is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.20% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
IMCC and
Correlation & Price change
A.I.dvisor tells us that IMCC and TXMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and TXMD's prices will move in lockstep.
| Ticker / NAME | Correlation To IMCC | 1D Price Change % | ||
|---|---|---|---|---|
| IMCC | 100% | -2.31% | ||
| TXMD - IMCC | 25% Poorly correlated | +2.96% | ||
| ACB - IMCC | 24% Poorly correlated | -0.97% | ||
| SCYX - IMCC | 22% Poorly correlated | +0.57% | ||
| CTOR - IMCC | 22% Poorly correlated | +2.40% | ||
| SNDL - IMCC | 22% Poorly correlated | -0.71% | ||
More | ||||
TXMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, TXMD has been loosely correlated with LIEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TXMD jumps, then LIEN could also see price increases.
| Ticker / NAME | Correlation To TXMD | 1D Price Change % | ||
|---|---|---|---|---|
| TXMD | 100% | +2.96% | ||
| LIEN - TXMD | 36% Loosely correlated | +0.99% | ||
| IMCC - TXMD | 24% Poorly correlated | -2.31% | ||
| ACB - TXMD | 23% Poorly correlated | -0.97% | ||
| BCRX - TXMD | 22% Poorly correlated | -1.31% | ||
| SBFM - TXMD | 22% Poorly correlated | +3.64% | ||
More | ||||